HirschIB. Insulin delivery in the T1D Exchange Clinic Registry: factors associated with pump use, discontinuation, clinical outcomes. Presented at the Advanced Technologies and Treatments for Diabetes Annual Meeting, Barcelona, SpainBarcelona>February 10, 2012.
3.
GargSK. Self-monitoring of blood glucose (SMBG), continuous glucose monitoring (CGM), HbA1c. Presented at the Advanced Technologies and Treatments for Diabetes Annual Meeting, Barcelona, Spain, February 10, 2012.
4.
WilliSM. Diabetic ketoacidosis, severe hypoglycemia in relation to pump, sensor use in the T1D Exchange Clinic Registry. Presented at the Advanced Technologies and Treatments for Diabetes Annual Meeting, Barcelona, Spain, February 10, 2012.
5.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med, 1993; 329:977–986.
6.
CryerPE. Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am, 2010; 39:641–654.
7.
GargS, BrazgRL, BaileyTS, BuckinghamBB, SloverRH, KlonoffDC, ShinJ, WelshJB, KaufmanFR. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE Study. Diabetes Technol Ther, 2012; 14:205–209.
8.
MudaliarSR, LindbergFA, JoyceM, BeerdsenP, StrangeP, LinA, HenryRR. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared to human regular insulin in healthy nondiabetic subjects. Diabetes Care, 1999; 22:1501–1506.
9.
AttiaN, JonesTW, HolcombeJ, TamborlaneWV. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and treatment of acutely compensated IDDM. Diabetes Care, 1998; 21:817–821.
10.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group:. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care, 2009; 32:1378–1383.
11.
RajuB, ArbelaezAM, BreckenridgeSM, CryerPE. Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments. J Clin Endocrinol Metab, 2006; 91:2087–2092.
12.
www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm259301.htm. 2012 February 4.
